These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36169665)

  • 1. Being the ultimate travel companion of a patient with uterine leiomyosarcoma.
    Grignani G; Merlini A; Aliberti S
    Future Oncol; 2022 Sep; 18(29s):17-23. PubMed ID: 36169665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
    Ricci S; Stone RL; Fader AN
    Gynecol Oncol; 2017 Apr; 145(1):208-216. PubMed ID: 28209496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Morcellation Debate: The History and the Science.
    Adelman MR
    Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion, Number 822.
    Obstet Gynecol; 2021 Mar; 137(3):e63-e74. PubMed ID: 33595252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
    Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
    J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
    Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
    J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
    Zullo F; Venturella R; Raffone A; Saccone G
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Leiomyosarcoma at Surgery for Presumed Uterine Myomas in Different Age Groups.
    Rey Valzacchi GM; Rosas P; Uzal M; Gil SJ; Viglierchio VT
    J Minim Invasive Gynecol; 2020; 27(4):926-929. PubMed ID: 31260748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
    Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
    Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
    Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
    J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
    Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
    Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
    Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
    Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
    Ludwin A; Gawron I; Pityński K
    Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
    Skorstad M; Kent A; Lieng M
    Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines.
    Glaser LM; Friedman J; Tsai S; Chaudhari A; Milad M
    Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():99-112. PubMed ID: 29078975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.